Affiliation:
1. Faculty of Medicine and Dentistry Blizard Institute Queen Mary University of London London UK
2. University of Westminster School of Life Sciences London UK
3. Department of Colorectal Surgery Barts Health NHS Trust The Royal London Hospital London UK
4. Department of Pathology Barts Health NHS Trust The Royal London Hospital London UK
Abstract
AbstractBackground & AimsThe long‐term effects of chemoradiotherapy on human rectum are poorly understood. The aims were to investigate changes in inflammatory status, myenteric neuron numbers/phenotype, neuromuscular functions and prokinetic drug efficacy.MethodsMacroscopically normal proximal‐to‐mid rectum was obtained from 21 patients undergoing surgery for bowel cancer, 98 days (range: 63–350) after concurrent capecitabine and pelvic radiotherapy, and 19 patients without chemoradiotherapy. Inflammatory status was measured by H&E, CD45 staining and qPCR. Myenteric neurons were examined by immunohistochemistry. Neuromuscular functions and drug efficacy were studied using exogenous agents and electrical field stimulation (EFS) to activate intrinsic nerves.ResultsInflammation was not detected. Numbers of myenteric ganglia/neurons were unchanged (11.7 ± 2.4 vs. 10.3 ± 2.2 neurons/mm myenteric plexus with/without chemoradiotherapy) as were the numbers of cholinergic/nitrergic neurons. EFS stimulated cholinergic and nitrergic neurons so the contractile response of the muscle was the sum of both but dominated by cholinergic (causing contraction) or less often, nitrergic activity (relaxation), followed, after termination of EFS, by neuronally mediated contraction. Inhibition of nitric oxide synthase (by L‐NAME 300 μM) more clearly defined EFS‐evoked contractions. The 5‐HT4 agonist prucalopride 10 μM and the cholinesterase inhibitor donepezil 1 µM, respectively increased and greatly increased the composite contractile response to EFS (measured as ‘area‐under‐the curve’) and the contractions isolated by L‐NAME (respectively, by 22 ± 14% and 334 ± 87%; n = 11/8). After chemoradiotherapy, nitrergic‐mediated muscle relaxations occurred more often during EFS (in 29.8 ± 6.1% preparations vs. 12.6 ± 5.1% without chemoradiotherapy, n = 21/18). With L‐NAME, the ability of prucalopride to facilitate EFS‐evoked contraction was lost and that of donepezil approximately halved (contractions increased by 132 ± 36%; n = 8).ConclusionsSeveral months after chemoradiotherapy, the rectum was not inflamed and myenteric neuron numbers/phenotype unchanged. However, nitrergic activity was increased relative to cholinergic activity, and prokinetic‐like drug activity was lost or greatly reduced. Thus, chemoradiotherapy causes long‐term changes in neuromuscular functions and markedly reduces the efficacy of drugs for treating constipation.
Funder
Bowel and Cancer Research
Dunhill Medical Trust
Age UK
Takeda Pharmaceuticals U.S.A.
Reference34 articles.
1. The challenges of colorectal cancer survivorship;Delinger CS;J Natl Comp Canc Netw,2009
2. Development and external validation of a nomogram and online tool to predict bowel dysfunction following restorative rectal cancer resection: the POLARS score;Battersby NJ;Gut,2018
3. Late Side Effects and Quality of Life After Radiotherapy for Rectal Cancer
4. Impact of chemotherapy on gastrointestinal functions and the enteric nervous system